无处不在的线粒体肌酸激酶CKMT1在乳腺癌进展中的上下文依赖的作用
Vinay Ayyappan1, Nicole M Jenkinson1, Caitlin M Tressler1
1Johns Hopkins University In Vivo Cellular and Molecular Imaging Center, Division of Cancer Imaging Research, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cell reports
|April 14, 2024
概括
线粒体肌酸激酶 (CKMT1) 在转移性乳腺癌中驱动肌酸水平. 它在转移中的下调增加了活性氧物种 (ROS),促进了癌细胞的迁移和入侵.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌细胞生物学 癌细胞生物学
背景情况:
- 代谢重编程是癌症的一个关键标志,支持癌症的快速扩散,入侵和转移.
- 肌酸代谢在乳腺癌进展中的作用是复杂的和有争议的.
- 线粒体肌酸激酶 (CKMT1) 在细胞能量恒温中发挥着关键作用.
研究的目的:
- 为了研究线粒体肌酸激酶 (CKMT1) 在乳腺癌转移中的作用.
- 阐明CKMT1表达,肌酸水平和转移潜力之间的关系.
- 了解CKMT1影响癌细胞迁移和入侵的潜在机制.
主要方法:
- 在原发性和转移性乳腺癌细胞系和瘤中分析CKMT1表达.
- 在癌细胞中测量肌酸水平和线粒体反应性氧物种 (ROS).
- 细胞迁移和入侵试验的评估,有或没有抗氧化剂治疗.
主要成果:
- 在初级瘤中,CKMT1的表达很高,促进细胞活力,但在转移性瘤中下调.
- 降低CKMT1的调节导致转移性乳腺癌细胞中线粒体ROS水平的增加.
- 由于CKMT1下调而增加的ROS通过对粘附和降解因子的上调来增强细胞迁移和入侵.
- 抗氧化剂治疗逆转了与CKMT1下调相关的亲迁移和侵入性影响.
结论:
- 在乳腺癌转移期间,CKMT1的表达受到严格调节.
- 对CKMT1的下调有助于转移性表型,通过增加ROS和促进细胞迁移和入侵.
- 向CKMT1或管理ROS水平可能为转移性乳腺癌提供治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K


